These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36631212)

  • 1. Sex Disparities in Familial Hypercholesterolemia.
    Jiménez A; Viñals C; Marco-Benedí V; González P; Domenech M; Suárez-Tembra M; Pinto X; Ortega E
    J Am Coll Cardiol; 2023 Jan; 81(2):203-205. PubMed ID: 36631212
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical features, diagnosis and frequency of familial hypercholesterolemia.
    Khachadurian AK
    Beitr Infusionsther; 1988; 23():26-32. PubMed ID: 2484779
    [No Abstract]   [Full Text] [Related]  

  • 3. What Is the Prevalence of Familial Hypercholesterolemia?
    Brunham LR; Hegele RA
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2629-2631. PubMed ID: 34433299
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial Commentary: What Determines the Risk of Cardiovascular Disease in Familial Hypercholesterolemia?
    Brunham LR; Mancini GBJ
    Trends Cardiovasc Med; 2021 May; 31(4):216-217. PubMed ID: 32407995
    [No Abstract]   [Full Text] [Related]  

  • 5. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Hopkins PN; Toth PP; Ballantyne CM; Rader DJ;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S9-17. PubMed ID: 21600530
    [No Abstract]   [Full Text] [Related]  

  • 6. Global Familial Hypercholesterolaemia Studies Collaboration (FHSC).
    Stock JK
    Atherosclerosis; 2021 Nov; 337():57-58. PubMed ID: 34686380
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter by Tromp et al Regarding Article, "Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland".
    Tromp TR; Hovingh GK; Reeskamp LF
    Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e44-e45. PubMed ID: 34936472
    [No Abstract]   [Full Text] [Related]  

  • 8. Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid Association.
    Hemphill L; Goldberg A; Hovingh K; Cohen J; Karalis DG
    J Gen Intern Med; 2020 Jul; 35(7):2225-2227. PubMed ID: 31950403
    [No Abstract]   [Full Text] [Related]  

  • 9. Response by Björnsson et al to Letter Regarding Article, "Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland".
    Björnsson E; Thorgeirsson G; Helgadóttir A; Gudbjartsson DF; Hólm H; Thorsteinsdóttir U; Sulem P; Stefánsson K
    Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e46-e47. PubMed ID: 34936471
    [No Abstract]   [Full Text] [Related]  

  • 10. Results and Lessons of a Pilot Study of Cascade Screening for Familial Hypercholesterolemia in US Primary Care Practices.
    Neuner J; Dimmock D; Kirschner AP; Beaudry H; Paradowski J; Orlando L
    J Gen Intern Med; 2020 Jan; 35(1):351-353. PubMed ID: 31667742
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial hypercholesterolemia--epidemiology, diagnosis, and screening.
    Singh S; Bittner V
    Curr Atheroscler Rep; 2015; 17(2):482. PubMed ID: 25612857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for familial hypercholesterolemia: what is the most effective strategy?
    Daniels SR
    Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):130-1. PubMed ID: 18059381
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum.
    Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior-Waluś B; Imiela J; Jankowski P; Kłosiewicz-Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T
    Pol Arch Med Wewn; 2013; 123(1-2):7-10. PubMed ID: 23449188
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening and management of familial hypercholesterolemia.
    Santos RD
    Curr Opin Cardiol; 2019 Sep; 34(5):526-530. PubMed ID: 31393421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Familial hypercholesterolemia: A largely underestimated cardiovascular risk].
    Ferrières J; Bruckert É; Béliard S; Rabès JP; Farnier M; Krempf M; Cariou B; Danchin N
    Ann Cardiol Angeiol (Paris); 2018 Feb; 67(1):1-8. PubMed ID: 28576280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single Nucleotide Variants Associated With Polygenic Hypercholesterolemia in Families Diagnosed Clinically With Familial Hypercholesterolemia.
    Lamiquiz-Moneo I; Pérez-Ruiz MR; Jarauta E; Tejedor MT; Bea AM; Mateo-Gallego R; Pérez-Calahorra S; Baila-Rueda L; Marco-Benedí V; de Castro-Orós I; Cenarro A; Civeira F
    Rev Esp Cardiol (Engl Ed); 2018 May; 71(5):351-356. PubMed ID: 28919240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum].
    Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior Waluś B; Imiela J; Jankowski P; Kłosiewicz Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T;
    Kardiol Pol; 2013; 71(1):107-11. PubMed ID: 23348551
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of heterozygous familial hypercholesterolemia - a local perspective.
    Bułdak Ł
    Endokrynol Pol; 2021; 72(3):189-190. PubMed ID: 34292576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Is Familial Hypercholesterolemia, and Why Does It Matter?
    Khera AV; Hegele RA
    Circulation; 2020 Jun; 141(22):1760-1763. PubMed ID: 32479201
    [No Abstract]   [Full Text] [Related]  

  • 20. Familial hypercholesterolemia: experience from the French-Canadian population.
    Paquette M; Genest J; Baass A
    Curr Opin Lipidol; 2018 Apr; 29(2):59-64. PubMed ID: 29356704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.